Clinical value of bundled care protocols in enhancing postoperative recovery among lung cancer patients

To evaluate the clinical value of bundled care protocols in enhancing postoperative recovery among lung cancer patients.

This was a retrospective study. A total of 120 patients undergoing radical lung cancer surgery in the thoracic surgery department of Affiliated Hospital of Hebei University from November 2022 to November 2024 were enrolled randomly assigned to the study group and the control group using a random number table (n=60 each group). The control group received routine nursing care, while the study group was managed using a bundled care protocol. Indicators including pulmonary function parameters, immune status, postoperative complication rates, quality-of-life scores and satisfaction levels were compared between the two groups before and after the intervention.

Post-intervention, the study group demonstrated significant improvements in FEV1, FVC, FEV1/FVC and PEF values compared to the control group(P=0.00). Immune indicators, including CD3⁺, CD4⁺ and CD4⁺/CD8⁺, in the study group were also markedly higher than those in the control group(P=0.00). The incidence of postoperative complications was 8% in the study group, markedly lower than the 23% observed in the control group (P=0.02). Post-intervention, KPS scores and SF-36 quality-of-life scores were significantly higher in the study group compared to the control group(P=0.00). Patient satisfaction in the study group reached 100%, compared to 90% in the control group, with a statistically significant difference(P=0.01).

Bundled care protocols demonstrate significant clinical benefits for lung cancer patients undergoing surgical treatment, including enhanced pulmonary function recovery, improved immune reconstitution, reduced postoperative complication rates and elevated quality of life and care satisfaction.